摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Boc-Lys(ClZ)-OH | 33640-54-9

中文名称
——
中文别名
——
英文名称
N-Boc-Lys(ClZ)-OH
英文别名
Boc-Lys(ClZ);(2S)-6-[(4-chlorophenyl)methoxycarbonylamino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
N-Boc-Lys(ClZ)-OH化学式
CAS
33640-54-9
化学式
C19H27ClN2O6
mdl
——
分子量
414.886
InChiKey
YDJSVDYWIDEWFB-HNNXBMFYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.71
  • 重原子数:
    28.0
  • 可旋转键数:
    9.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    113.96
  • 氢给体数:
    3.0
  • 氢受体数:
    5.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-Boc-Lys(ClZ)-OHsodium hydroxide 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 15.0h, 生成 3-[(S)-2-tert-Butoxycarbonylamino-6-(4-chloro-benzyloxycarbonylamino)-hexanoylamino]-benzoic acid
    参考文献:
    名称:
    Template Assembled Synthetic Proteins (TASPs). Are Template Size, Shape, and Directionality Important in Formation of Four-Helix Bundles?
    摘要:
    A series of rigid aromatic templates that vary in size, shape, and directionality have been investigated in template-assembled synthetic 4 alpha-helix peptide bundles for their capacity to enhance the alpha-helicity of an amphiphilic peptide (DAATALANALKKL-[NHCH2CH2SH]). In aqueous phosphate buffer (10 mM, pH 7) the peptide has some innate helicity (similar to 30%) which is concentration-independent between 1 and 250 mu M. Helicity is enhanced to 64-75% when 4 equiv of the peptide are connected to aromatic templates based on benzene, benzanilide, or a cyclic octapeptide. This effect is concentration-independent by circular dichroism spectroscopy (3-60 mu M [TASP]), the TASPs are monomeric by sedimentation equilibrium experiments, and have comparable thermodynamic stabilities. Thus these templates induce intra-rather than inter-molecular peptide association and are equally effective despite variations in size, shapes and directionality. When the linker between the template and peptides is sufficently long, as in these cases, TASP formation is less sensitive to the dimensions of the template than to the communication between hydrophobic peptide side chains, which are the main determinants of helix separation, 4 alpha-helix bundle size and stability. This greatly simplifies approaches to developing small molecule mimetics of interacting protein surfaces. However template size, shape, and directionality may still be important when the linker is short or when assembled peptide surfaces are isolated from one another and unable to communicate.
    DOI:
    10.1021/ja971951o
点击查看最新优质反应信息

文献信息

  • Design, synthesis, and in vitro activity of bis(succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activity
    作者:John C. Cheronis、Eric T. Whalley、Lisa G. Allen、Sharon D. Loy、Megan W. Elder、Matthew J. Duggan、Kelly L. Gross、James K. Blodgett
    DOI:10.1021/jm00029a006
    日期:1994.2
    based on the B2 antagonist D-Arg0-[Hyp3,D-Phe7,Leu8]-BK (1) and the B1 antagonist Lys0-[Leu8,des-Arg9]-BK (7) that are potent antagonists of both B1 and B2 receptors. From this series, compound 50 (alternatively, CP-0364), the 1,6-bis(succinimido)hexane heterodimer of D-Arg0-[Hyp3,Cys6,D-Phe7,Leu8]-BK (2), and D-Arg0-[Cys1,Hyp3,Leu8,des-Arg9]-BK (6), was found to be the most active both in vitro and
    我们基于B2拮抗剂D-Arg0- [Hyp3,D-Phe7,Leu8] -BK(1)和B1拮抗剂Lys0- [Leu8,des-Arg9] -BK(7)开发了一系列肽异二聚体是B1和B2受体的有效拮抗剂。从该系列化合物50(或者CP-0364),D-Arg0- [Hyp3,Cys6,D-Phe7,Leu8] -BK(2)和D-的1,6-双(琥珀酰亚胺基)己烷异二聚体发现Arg0- [Cys1,Hyp3,Leu8,des-Arg9] -BK(6)在体外和体内都是最活跃的。当针对缓激肽(BK)诱导的大鼠子宫平滑肌收缩进行测量时,化合物50的pA2为8.3,针对[des-Arg9] -BK诱导的兔主动脉平滑肌收缩的IC50约为10(-8)M。
  • Potent vasopressin antagonist modified at the carboxy-terminal tripeptide tail
    作者:Fadia El-Fehail Ali、Hsin Lan Chang、William F. Huffman、Grace Heckman、Lewis B. Kinter、Edwin F. Weidley、Richard Edwards、Dulcie Schmidt、Daryl Ashton-Shue、Frans L. Stassen
    DOI:10.1021/jm00395a019
    日期:1987.12
    V2-receptor antagonists. Similar modification of a representative agonist drastically reduces its potency. We report the synthesis and pharmacological properties of a series of potent V2-receptor antagonists 3-9 where a combination of D or L dibasic dipeptide has been utilized to replace the common tripeptide fragment. Our results suggest a difference in the way agonists and antagonists bind to vasopressin
    在不断努力设计更有效的肾血管加压素(V2受体)拮抗剂时,我们将注意力集中在了羧基末端三肽尾巴(Pro-Arg-Gly-NH2)上,这是激动剂和拮抗剂共同的片段。直接连接在环六肽环上的具有二元二肽尾巴的加压素拮抗剂类似物是有效的V2受体拮抗剂,例如,Arg-Arg-NH2或Arg-Lys-NH2。代表性激动剂的类似修饰极大地降低了其效力。我们报告了一系列有效的V2受体拮抗剂3-9的合成和药理特性,其中D或L二元二肽的组合已被用来替代常见的三肽片段。我们的结果表明,激动剂和拮抗剂与血管加压素受体结合的方式有所不同,并进一步支持了激动剂和拮抗剂的结构活性关系上的差异。这些结果为新型V2受体拮抗剂的设计提供了潜在有用的见解。
  • Design, Synthesis, and Evaluation of Phe-Gly Mimetics:  Heterocyclic Building Blocks for Pseudopeptides
    作者:Susanna Borg、Roeland C. Vollinga、Maryse Labarre、Kemal Payza、Lars Terenius、Kristina Luthman
    DOI:10.1021/jm990197+
    日期:1999.10.1
    ring systems have been synthesized as building blocks in the synthesis of pseudopeptides. Three derivatives (1-3) have the carboxylic acid function directly bound to the heterocyclic ring, and three derivatives (4-6) have an extra methylene group between the heterocyclic ring and the acid function to allow for an increased conformational flexibility. The mimetics were used as Phe-Gly replacements in
    含有1,3,4-恶二唑,1,2,4-恶二唑1,2,4-三唑环系统的对映体杂环Boc保护的Phe-Gly二肽模拟物是伪肽合成中的结构单元。三个衍生物(1-3)具有直接键合到杂环上的羧酸官能团,并且三个衍生物(4-6)在杂环和酸官能团之间具有额外的亚甲基,以提高构象柔韧性。该模拟物用作生物活性肽dermorphin(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH(2))和P物质(Arg-Pro-Lys-Pro-Gln的Phe-Gly替代品) -Gln-Phe-Phe-Gly-Leu-MetNH(2),SP)。使用Boc化学方法在MBHA树脂上使用固相方法进行假肽合成。通过测试dermorphin假肽的微阿片受体亲和力和SP假肽的NK(1)受体亲和力来进行生物学评估。结果表明,除3个模拟物外,其他所有模拟物均是dermorphin中Phe-Gly的极佳替代品,因为它们对微受体(IC(50)=
  • Solid-phase synthesis of peptides using allylic anchoring groups. An investigation of their palladium-catalysed cleavage
    作者:Paul Lloyd-Williams、Gemma Jou、Fernando Albericio、Ernest Giralt
    DOI:10.1016/s0040-4039(00)79906-0
    日期:1991.8
    The use of two different allylic “handles” has been investigated in the solid-phase synthesis of protected peptides. Very high yields for the cleavage of peptides from the resin, under mild conditions which preserve side-chain protecting groups can be achieved by carrying out the cleavage reaction in 2:2:1 THF/DMSO/0.5 M HCl, using morpholine as nucleophile and Pd(Ph3P)4 as catalyst.
    在保护肽的固相合成中,已经研究了两种不同烯丙基“手柄”的使用。通过在2:2:1 THF / DMSO / 0.5 M HCl中使用吗啉作为亲核试剂和以Pd(Ph 3 P)4为催化剂。
  • An Efficient Procedure for Synthesis of Phosphopeptides through the Benzyl Phosphate-Protection by the Boc Mode Solid-Phase Method
    作者:Tateaki Wakamiya、Kunio Saruta、Shoichi Kusumoto、Kiichiro Nakajima、Kumiko Yoshizawa-Kumagaye、Shinobu Imajoh-Ohmi、Shiro Kanegasaki
    DOI:10.1246/cl.1993.1401
    日期:1993.8
    The benzyl phosphate-protection for phosphoamino acid is very useful for Boc mode solid-phase synthesis of phosphopeptides. A phosphothreonine-containing peptide related to the EGF receptor protein was synthesized by use of this methodology.
    苄基磷酸盐对磷酸氨基酸的保护在Boc模式固相合成肽中非常有用。利用这种方法合成了与EGF受体蛋白相关的含磷酸酸的肽。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫